Vision Innovation Partners has acquired Ophthalmic Associates of Alexandria, enhancing its eye care capabilities in the Virginia market.
Information on the Target
Vision Innovation Partners (VIP), a prominent eye care organization in the Mid-Atlantic region, has successfully acquired Ophthalmic Associates of Alexandria, a comprehensive ophthalmology practice located in the heart of Alexandria, Virginia. Established in 2010, Ophthalmic Associates is known for delivering high-quality eye care and medical treatments to the local community. The practice is managed by Dr. Jacob Clark, a board-certified ophthalmologist, who leads a multi-specialty team employing advanced technology for various procedures, including eyeglass fittings, laser surgeries, and management of ophthalmic diseases such as glaucoma and cataracts.
This acquisition represents the 27th addition to VIP’s portfolio since its inception in 2017, significantly enhancing its presence in a key metropolitan market. With a commitment to improving patient outcomes, VIP’s strategy consolidates a network of ophthalmology centers, bolstering its capability to provide comprehensive eye care services across the region.
Access Full Deal Insights
You’re viewing a public preview of this deal. To unlock full access to ca. 50,000 other deals in our database and join ca. 400 M&A professionals who are using it daily, sign up for Dealert.
Industry Overview in the Target's Specific Country
The ophthalmology industry in the United States remains robust, driven by an aging population and increasing prevalence of ocular diseases. As a vital segment of the healthcare market, ophthalmology services are increasingly
Similar Deals
Bambu Ventures → Lemonaid Health
2026
Main Street Capital Corporation → leading healthcare data services provider
2026
Prime Healthcare → Franciscan Health Olympia Fields
2026
Heartland Dental → Smile Design Dentistry
2025
Sun Pharmaceutical Industries Limited → Checkpoint Therapeutics, Inc.
2025
Bessemer Investors, LLC → Xanitos Inc.
2025
Vision Innovation Partners
invested in
Ophthalmic Associates of Alexandria
in 2026
in a Buyout deal